MTVA

MetaVia Inc. Common Stock

1.43

USD

+0.34

+31.19%

Nov 06, 15:59 UTC -5

Closed

Pre-Market

1.39

-0.04

-2.80%

MetaVia Inc. Common Stock (MTVA) Earnings

MTVA Earnings Reports

Positive Surprise Ratio

MTVA beat 19 of 34 last estimates.

56%

Next Report

Date of Next Report

Mar 24, 2027

Estimate for Q4 26 (Revenue/ EPS)

-$0.76

Implied change from Q3 26 (Revenue/ EPS)

Implied change from Q4 25 (Revenue/ EPS)

+80.95%

MetaVia Inc. Common Stock earnings per share and revenue

On Nov 06, 2026, MTVA reported earnings of -- USD per share (EPS) for Q3 26, -- the estimate of -0.74 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.

Looking ahead to Q4 26, -- analysts forecast an EPS of -0.76 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Aligos Therapeutics, Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$2.21

Actual

-$2.09

Surprise

+5.58%

CervoMed Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.49

Actual

-$0.39

Surprise

+21.97%

Creative Medical Technology Holdings, Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.24

Actual

-$0.40

Surprise

-63.40%

Medicus Pharma Ltd. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$6.75

Actual

-$11.64

Surprise

-72.25%

Moderna, Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$1.27

Actual

$0.38

Surprise

+129.79%

Bio-Techne Corp.

Report Date

Nov 06, 2026 For Q1 27

Estimate

$0.44

Actual

$0.44

Surprise

-1.96%

Immunocore Holdings plc - ADR

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.13

Actual

-$0.28

Surprise

-104.08%

Entera Bio Ltd. Ordinary Shares

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.06

Actual

-$0.11

Surprise

-58.50%

Vogenx Inc Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.16

Actual

-$0.47

Surprise

-187.99%

Agenus Inc.

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.27

Actual

$0.02

Surprise

+107.26%

FAQ

What were MetaVia Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?

For Q3 2026, MetaVia Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.

How did the market react to MetaVia Inc. Common Stock's Q3 2026 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is MetaVia Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 24, 2027.

What are the forecasts for MetaVia Inc. Common Stock's next earnings report?

Based on -- analysts, MetaVia Inc. Common Stock is expected to report EPS of -$0.76 and revenue of -- for Q4 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.